# Efficacy and Safety Study of SHR117887 in Combination With Metformin in Patients With Type 2 Diabetes

> **NCT01984489** · PHASE2 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 120 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Placebo
- **DRUG:** SHR117887

## Key facts

- **NCT ID:** NCT01984489
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2013-05
- **Final completion:** 2013-08
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2013-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01984489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01984489, "Efficacy and Safety Study of SHR117887 in Combination With Metformin in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01984489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*